JP2015530094A5 - - Google Patents

Download PDF

Info

Publication number
JP2015530094A5
JP2015530094A5 JP2015533022A JP2015533022A JP2015530094A5 JP 2015530094 A5 JP2015530094 A5 JP 2015530094A5 JP 2015533022 A JP2015533022 A JP 2015533022A JP 2015533022 A JP2015533022 A JP 2015533022A JP 2015530094 A5 JP2015530094 A5 JP 2015530094A5
Authority
JP
Japan
Prior art keywords
gene
accession number
swissprot accession
gimap5
areg
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015533022A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015530094A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/SG2013/000414 external-priority patent/WO2014046623A1/en
Publication of JP2015530094A publication Critical patent/JP2015530094A/ja
Publication of JP2015530094A5 publication Critical patent/JP2015530094A5/ja
Pending legal-status Critical Current

Links

JP2015533022A 2012-09-21 2013-09-23 対象の肝臓癌を診断する方法及び肝臓癌を診断するためのキット Pending JP2015530094A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261704425P 2012-09-21 2012-09-21
US61/704,425 2012-09-21
PCT/SG2013/000414 WO2014046623A1 (en) 2012-09-21 2013-09-23 Methods of diagnosing liver cancer in a subject and a kit for diagnosing liver cancer

Publications (2)

Publication Number Publication Date
JP2015530094A JP2015530094A (ja) 2015-10-15
JP2015530094A5 true JP2015530094A5 (enExample) 2016-10-20

Family

ID=50341782

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015533022A Pending JP2015530094A (ja) 2012-09-21 2013-09-23 対象の肝臓癌を診断する方法及び肝臓癌を診断するためのキット

Country Status (7)

Country Link
US (1) US20150232943A1 (enExample)
EP (1) EP2898099A4 (enExample)
JP (1) JP2015530094A (enExample)
KR (1) KR20150058465A (enExample)
CN (1) CN104812914B (enExample)
SG (1) SG11201502089QA (enExample)
WO (1) WO2014046623A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101843173B1 (ko) * 2014-10-24 2018-03-29 씨비에스바이오사이언스 주식회사 혈관 내피 세포 성장인자 수용체 억제제에 대한 감수성 예측 방법
KR102116178B1 (ko) 2017-05-10 2020-05-27 서울대학교산학협력단 간암 고위험군의 간암 발병 모니터링 또는 진단용 바이오마커 및 그 용도
CN108048422A (zh) * 2017-11-30 2018-05-18 天津市湖滨盘古基因科学发展有限公司 一种gtp酶,imap家族成员7突变蛋白及其应用
CN110241198A (zh) * 2019-05-30 2019-09-17 成都吉诺迈尔生物科技有限公司 一种表征hHRD同源重组缺陷的基因组重组指纹及其鉴定方法
CN111610262A (zh) * 2020-05-19 2020-09-01 上海鹿明生物科技有限公司 一种用于肝胆疾病诊断的代谢标志物
WO2025111814A1 (zh) * 2023-11-28 2025-06-05 何牮 一种b细胞的生物标志物组及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003081201A2 (en) * 2002-03-21 2003-10-02 Yissum Research Development Company Of The Hebrew University Of Jerusalem Peripheral blood cell markers useful for diagnosing multiple sclerosis and methods and kits utilizing same
US20070148648A1 (en) * 2003-11-04 2007-06-28 Martin Dugas Method for distinguishing who classified aml subtypes
EP1830289A1 (en) * 2005-11-30 2007-09-05 Institut National De La Sante Et De La Recherche Medicale (Inserm) Methods for hepatocellular carninoma classification and prognosis
WO2008138578A2 (en) * 2007-05-11 2008-11-20 Medical Prognosis Institute Methods, kits, and devices for identifying biomarkers of treatment response and use thereof to predict treatment efficacy
EP2687609B1 (en) * 2008-11-10 2017-01-04 The United States of America, as represented by The Secretary, Department of Health and Human Services Method for treating solid tumor

Similar Documents

Publication Publication Date Title
WO2015176066A3 (en) Lpa-associated protein and rna expression
Mohammadi et al. Organ-specific proteomic analysis of drought-stressed soybean seedlings
Lawal et al. Progress and recent advances in fabrication and utilization of hypoxanthine biosensors for meat and fish quality assessment: a review
CY1121934T1 (el) Αντισωματα anti-fcrn
JP2014098143A5 (enExample)
HUE042471T2 (hu) Madárpatogéneket expresszáló, rekombináns, gallid herpeszvírus 3 (MDV 2-es szerotípus) vektorok és alkalmazásuk
MX372950B (es) Anticuerpos.
JP2011136997A5 (enExample)
JP2017522908A5 (enExample)
EP3636170C0 (en) DURATION-DEPENDENT EVALUATION OF SENSOR DATA TO DETERMINE STABILITY, CREEP AND VISCOELASTIC MEASUREMENT ELEMENTS
HUE029140T2 (hu) Fitázok, ezeket kódoló nukleinsavak, valamint eljárások az elõállításukra és alkalmazásuk
JP2011004745A5 (enExample)
JP2014039567A5 (enExample)
WO2016107818A8 (en) Compositions and methods for protein glycosylation
LT2945642T (lt) Faktoriaus 1 baltymas, skirtas naudoti ligų gydymui arba prevencijai
MA47775A (fr) Contrôle des glycoformes afucosylées totales d'anticorps produits en culture cellulaire
CL2012001068A1 (es) Polinucleotido que codifica oleosina modificada incluyendo al menos una cisteina introducida artificialmente, constructo genetico que comprende dicho polinucleotido; célula huesped; composicion que comprende un cuerpo oleoso; alimento animal que comprende el cuerpo oleoso.
EP4481045A3 (en) Dna-binding protein using ppr motif, and use thereof
WO2012087160A3 (en) Anti-inflammatory proteins and methods of preparation and use thereof
MA52186A (fr) Glycoformes afucosylées totales d'anticorps produits en culture cellulaire
MX2015015274A (es) Ruta de ácido organico novedosa.
EP3243830A4 (en) Protein associated with disease resistance and encoding gene thereof, and use thereof in regulation of plant disease resistance
MX383506B (es) Parvovirus porcino.
WO2014140362A3 (en) Lymphocyte biomarkers for determining the clinical response to therapy with mesenschymal stromal cells(msc)
JP2016528914A5 (enExample)